Mid-Trimester Amniocentesis Fetal Loss Rate

R. Douglas Wilson; Sylvie Langlois; Jo Ann Johnson; Valerie Desilets; François Audibert; Alain Gagnon; Philip Wyatt; Victoria Allen; Claire Blight; David Chitayat; Sandra A. Farrell; Tanya Nelson; Sarah M. Nikkel; David Skidmore

doi:10.1016/S1701-2163(16)32501-4

Mid-Trimester Amniocentesis Fetal Loss Rate

R. Douglas Wilson, Sylvie Langlois, Jo Ann Johnson, Valerie Desilets, François Audibert, Alain Gagnon, Philip Wyatt, Victoria Allen, Claire Blight, David Chitayat, Sandra A. Farrell, Tanya Nelson, Sarah M. Nikkel, David Skidmore

Medicine

Résultat de recherche: Article › examen par les pairs

35 Citations (Scopus)

Résumé

Objective: To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome: Reduction of benign biopsy rates. Benefits: To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement: The risk of postprocedure loss is unique to the individual and is based on multiple variables.

Langue d'origine	English
Pages (de-à)	586-590
Nombre de pages	5
Journal	Journal of Obstetrics and Gynaecology Canada
Volume	29
Numéro de publication	7
DOI	https://doi.org/10.1016/S1701-2163(16)32501-4
Statut de publication	Published - 2007

Note bibliographique

Publisher Copyright:
© 2007 Society of Obstetricians and Gynaecologists of Canada.

ASJC Scopus Subject Areas

Obstetrics and Gynaecology

Accès au document

10.1016/S1701-2163(16)32501-4

Autres fichiers et liens

Citer

@article{725b097fb8be46b7b6e41dda03693362,

title = "Mid-Trimester Amniocentesis Fetal Loss Rate",

abstract = "Objective: To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome: Reduction of benign biopsy rates. Benefits: To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement: The risk of postprocedure loss is unique to the individual and is based on multiple variables.",

author = "Wilson, {R. Douglas} and Sylvie Langlois and Johnson, {Jo Ann} and Valerie Desilets and Fran{\c c}ois Audibert and Alain Gagnon and Philip Wyatt and Victoria Allen and Claire Blight and David Chitayat and Farrell, {Sandra A.} and Tanya Nelson and Nikkel, {Sarah M.} and David Skidmore",

note = "Publisher Copyright: {\textcopyright} 2007 Society of Obstetricians and Gynaecologists of Canada.",

year = "2007",

doi = "10.1016/S1701-2163(16)32501-4",

language = "English",

volume = "29",

pages = "586--590",

journal = "Journal of Obstetrics and Gynaecology Canada",

issn = "1701-2163",

publisher = "Healthcare & Financial Pub.",

number = "7",

}

TY - JOUR

T1 - Mid-Trimester Amniocentesis Fetal Loss Rate

AU - Wilson, R. Douglas

AU - Langlois, Sylvie

AU - Johnson, Jo Ann

AU - Desilets, Valerie

AU - Audibert, François

AU - Gagnon, Alain

AU - Wyatt, Philip

AU - Allen, Victoria

AU - Blight, Claire

AU - Chitayat, David

AU - Farrell, Sandra A.

AU - Nelson, Tanya

AU - Nikkel, Sarah M.

AU - Skidmore, David

PY - 2007

Y1 - 2007

N2 - Objective: To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome: Reduction of benign biopsy rates. Benefits: To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement: The risk of postprocedure loss is unique to the individual and is based on multiple variables.

AB - Objective: To determine the postprocedure loss rate for mid-trimester genetic amniocentesis. Outcome: Reduction of benign biopsy rates. Benefits: To provide better advice for women about the risks and benefits of mid-trimester genetic amniocentesis, and to ensure that women are given sufficient information/counselling to make a decision about screening. Summary Statement: The risk of postprocedure loss is unique to the individual and is based on multiple variables.

UR - http://www.scopus.com/inward/record.url?scp=35548971227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35548971227&partnerID=8YFLogxK

U2 - 10.1016/S1701-2163(16)32501-4

DO - 10.1016/S1701-2163(16)32501-4

M3 - Article

C2 - 17623573

AN - SCOPUS:35548971227

SN - 1701-2163

VL - 29

SP - 586

EP - 590

JO - Journal of Obstetrics and Gynaecology Canada

JF - Journal of Obstetrics and Gynaecology Canada

IS - 7

ER -

Mid-Trimester Amniocentesis Fetal Loss Rate

Résumé

Note bibliographique

ASJC Scopus Subject Areas

Accès au document

Autres fichiers et liens

Empreinte numérique

Citer